Your browser doesn't support javascript.
loading
Clinical research of operation in the treatment for potentially resectable cancer of pancreatic body-tail / 天津医药
Tianjin Medical Journal ; (12): 728-732, 2018.
Article in Chinese | WPRIM | ID: wpr-809751
ABSTRACT
@#Objective Todiscusstheclinicaleffectandtechnicalmethodofthesurgicaltreatmentforpotentially resectablecancerofpancreaticbody-tail.Methods Elevenpatientswithpotentiallyresectablecancerofpancreaticbodytailoradjacentorganmetastasis,whounderwentwideexcisionandpostoperativechemotherapyinourdepartmentwere retrospectivelyanalyzed. Results Inelevenpatients,10patientswithadjacentorganmetastasiswereperformedinvolved organsresection,3patientsweregivenresectionoftheceliacaxis(CA)andcommonhepaticartery(CHA)and2patients weregiventotalgastrectomyandjejunalinterpositionpouchreconstruction.Onepatienthadprolongedhospitalstaydueto incisioninfection,butnoseriouscomplicationsoccurredinotherpatients.Exceptfor2patients,theotherpatientsunderwent postoperativechemotherapyofgemcitabine.Allofthepatientsachievedreliefthroughoperation.Themediansurvivaltime was 28 (14, 36) months. One and 3-year survival rates were 90.9% and 36.3%. Conclusion The resection rate of potentiallyresectablecarcinomaofpancreaticbodyandtailoperationislower,andpatientshavelongbeenplaguedby abdominal pain. The treatment of extensive resection operation and recessive resection and postoperative adjuvant chemotherapycanimprovethequalityoflifeandprolongthesurvivalrateofpatients.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Tianjin Medical Journal Year: 2018 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Tianjin Medical Journal Year: 2018 Type: Article